体外診断用酵素の世界市場レポート 2025年

体外診断用酵素市場は、がん罹患率の上昇により大きな成長が見込まれています。がんとは、細胞の異常な増殖と分裂を特徴とする疾患群を指し、健康な組織に脅威をもたらします。がんの有病率増加の要因としては、感染症、免疫系の機能不全、ホルモンの影響などが挙げられます。体外診断用（IVD）酵素は、がんの早期発見・診断から治療法の選択、モニタリング、個別化医療に至るまで、がん医療全般にわたる様々な診断・モニタリングアッセイにおいて重要な役割を果たしています。例えば、世界保健機関（WHO）は、2050年までに新たながん患者が2022年に比べて77％増加すると予測しており、がん管理における体外診断用酵素の必要性が高まっていることを強調しています。

体外診断用酵素市場の主要企業は、市場での地位を維持するために自己免疫疾患検出キットなどの革新的な製品に投資しています。これらのキットは、免疫系が誤って体の組織を攻撃する自己免疫疾患を検出するために設計されています。例えば、NeoDx Biotech Labs Pvt Ltd.は最近、イムノアッセイ、分子診断、抗体検出法などの先進技術を組み込んだ自己免疫疾患検出用IVDキットを発売しました。このキットは高い感度と特異性を備えており、臨床医は自己免疫疾患を迅速かつ正確に診断することができます。

2023年2月、SDバイオセンサー社とSJLパートナーズLLCはメリディアン・バイオサイエンス社を15億3,000万米ドルで買収しました。この買収により、SDバイオセンサーはメリディアンが持つ診断薬や免疫学的・分子学的検査の原材料に関する専門知識をさまざまな用途で活用できるようになりました。米国を拠点とするMeridian Bioscience Inc.は、体外診断用酵素および関連技術への貢献で知られています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界体外診断用酵素 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の体外診断用酵素市場：成長率分析
• 世界の体外診断用酵素市場の実績：規模と成長, 2019-2024
• 世界の体外診断用酵素市場の予測：規模と成長, 2024-2029, 2034F
• 世界体外診断用酵素総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の体外診断用酵素市場酵素の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• プロテアーゼ
• ポリメラーゼと転写酵素
• リボヌクレアーゼ
• その他の酵素の種類
• 世界の体外診断用酵素市場：疾患タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 感染症
• 糖尿病
• 腫瘍学
• 心臓病学
• 腎臓学
• 自己免疫疾患
• その他の病気の種類
• 世界の体外診断用酵素市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 組織学的アッセイ
• 分子診断
• 臨床化学
• その他のテクノロジー
• 世界の体外診断用酵素市場：最終用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 製薬およびバイオテクノロジー
• 病院および診断ラボ
• 契約調査機関（CRO）
• 学術ラボ
• 世界の体外診断用酵素市場プロテアーゼの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• トリプシン
• ペプシン
• プロテイナーゼK
• 世界の体外診断用酵素市場ポリメラーゼと転写酵素の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• DNAポリメラーゼ
• RNAポリメラーゼ
• 逆転写酵素
• 世界の体外診断用酵素市場リボヌクレアーゼの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• RNase A
• RNase H
• 世界の体外診断用酵素市場、その他の酵素タイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 脱水素酵素
• リパーゼ
• リガーゼ

第7章 地域別・国別分析

• 世界の体外診断用酵素市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の体外診断用酵素市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 体外診断用酵素市場：競合情勢
• 体外診断用酵素市場：企業プロファイル
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Becton Dickinson and Company
• Agilent Technologies Inc.
• Grifols SA
• Hologic Inc.
• Illumina Inc.
• Mindray Medical International Limited
• PerkinElmer Inc.
• bioMerieux SA
• QuidelOrtho Corporation
• Sysmex Corporation
• Bio-Rad Laboratories Inc.
• Qiagen N.V.
• DiaSorin SpA
• Promega Corporation
• Randox Laboratories Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 体外診断用酵素市場2029：新たな機会を提供する国
• 体外診断用酵素市場2029：新たな機会を提供するセグメント
• 体外診断用酵素市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

In vitro diagnostics (IVD) enzymes are specialized proteins used in diagnostic tests conducted outside the living organism, typically in a laboratory setting. These enzymes catalyze specific biochemical reactions that help detect, quantify, or monitor the presence of various substances, including pathogens, biomarkers, or other molecules relevant to diagnosing diseases.

The main enzyme types in the in vitro diagnostics enzymes market are proteases, polymerase and transcriptase, ribonuclease, and other enzyme types. Proteases refer to enzymes that catalyze the breakdown of proteins into smaller peptides or amino acids. Various disease types are targeted, including infectious diseases, diabetes, oncology, cardiology, nephrology, autoimmune diseases, and others. These enzymes are utilized in various technologies such as histology assays, molecular diagnostics, clinical chemistry, and others, and are used by end users such as pharmaceutical and biotech companies, hospitals and diagnostic labs, contract research organizations (CROs), and academic labs.

The in vitro diagnostics enzymes market research report is one of a series of new reports from The Business Research Company that provides in vitro diagnostics enzymes market statistics, including in vitro diagnostics enzymes industry global market size, regional shares, competitors with an in vitro diagnostics enzymes market share, detailed in vitro diagnostics enzymes market segments, market trends, and opportunities, and any further data you may need to thrive in the in vitro diagnostics enzymes industry. This in vitro diagnostics enzymes research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The in vitro diagnostics enzymes market size has grown strongly in recent years. It will grow from $2.14 billion in 2024 to $2.32 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to increasing incidence of diseases such as cancer and HIV/AIDS, growing need for diagnostic testing and monitoring of age-related diseases, shifts in lifestyle factors, including diet and physical activity, rise in approval of new diagnostic assays and products by regulatory authorities, and higher healthcare expenditures globally.

The in vitro diagnostics enzymes market size is expected to see strong growth in the next few years. It will grow to $3.17 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to increasing focus on personalized healthcare, growing healthcare infrastructure, rising disposable incomes in emerging markets, rise in collaborations between companies and research institutions, and increasing demand for rapid and convenient diagnostic solutions. Major trends in the forecast period include the adoption of microfluidics technologies, development of novel enzyme substrates and detection methods, use of point-of-care molecular diagnostic platforms integrated enzyme-based amplification techniques, integration of CRISPR-based technologies with enzyme assays, use of liquid biopsy techniques, and utilization of advanced data analytics and bioinformatics tools.

The in vitro diagnostics enzymes market is expected to grow significantly due to the rising prevalence of cancer. Cancer refers to a group of diseases characterized by abnormal cell growth and division, posing a threat to healthy tissues. Factors contributing to the increased prevalence of cancer include infectious agents, immune system dysfunctions, and hormonal influences. In vitro diagnostics (IVD) enzymes play a crucial role in various diagnostic and monitoring assays across the cancer care continuum, from early detection and diagnosis to treatment selection, monitoring, and personalized medicine. For example, the World Health Organization (WHO) projects a 77% increase in new cancer cases by 2050 compared to 2022, highlighting the growing need for in vitro diagnostics enzymes in cancer management.

Leading companies in the in vitro diagnostics enzymes market are investing in innovative products such as autoimmune disorder detection kits to maintain their market position. These kits are designed to detect autoimmune diseases, where the immune system mistakenly attacks the body's tissues. For instance, NeoDx Biotech Labs Pvt Ltd. recently launched an IVD kit for detecting autoimmune disorders, incorporating advanced technologies such as immunoassays, molecular diagnostics, and antibody detection methods. This kit offers high sensitivity and specificity, enabling clinicians to swiftly and accurately diagnose autoimmune conditions.

In February 2023, SD Biosensor Inc. and SJL Partners LLC acquired Meridian Bioscience Inc. for $1.53 billion. This acquisition allows SD Biosensor to leverage Meridian's expertise in diagnostic products and raw materials for immunological and molecular tests across various applications. Meridian Bioscience Inc., based in the US, is known for its contributions to in vitro diagnostic enzymes and related technologies.

Major companies operating in the in vitro diagnostics enzymes market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company, Agilent Technologies Inc., Grifols SA, Hologic Inc., Illumina Inc., Mindray Medical International Limited, PerkinElmer Inc., bioMerieux SA, QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., DiaSorin SpA, Promega Corporation, Randox Laboratories Ltd., Meridian Bioscience Inc., Fujirebio Diagnostics Inc., Sekisui Diagnostics LLC, Trivitron Healthcare, Codexis Inc., Amicogen Inc., EKF Diagnostics Holdings plc, Advanced Enzymes Technologies Ltd., Biocatalysts Ltd., Alpha Laboratories Ltd.

North America was the largest region in the in vitro diagnostics enzymes market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vitro diagnostics enzymes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the in vitro diagnostics enzymes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The in vitro diagnostics (IVD) enzymes market consists of revenues earned by entities by providing services such as enzyme engineering, custom enzyme production, validation services, promega custom assay services, and bio-techne enzyme solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The in vitro diagnostics (IVD) enzymes market also includes sales of Taq DNA polymerase, reverse transcriptase, alkaline phosphatase (ALP), horseradish peroxidase (HRP), DNA ligase, NEB enzyme products, and sigma-Aldrich diagnostic enzymes. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

In Vitro Diagnostics Enzymes Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on in vitro diagnostics enzymes market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for in vitro diagnostics enzymes ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The in vitro diagnostics enzymes market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Enzyme Type: Proteases; Polymerase And Transcriptase; Ribonuclease; Other Enzyme Types
• 2) By Disease Type: Infectious Disease; Diabetes; Oncology; Cardiology; Nephrology; Autoimmune Diseases; Other Disease Types
• 3) By Technology: Histology Assays; Molecular Diagnostics; Clinical Chemistry; Other Technologies
• 4) By End Use: Pharma And Biotech; Hospital And Diagnostic Labs; Contract Research Organizations (CROs); Academic Labs
• Subsegments:
• 1) By Proteases: Trypsin; Pepsin; Proteinase K
• 2) By Polymerase And Transcriptase: DNA Polymerase; RNA Polymerase; Reverse Transcriptase
• 3) By Ribonuclease: RNase A; RNase H
• 4) By Other Enzyme Types: Dehydrogenases; Lipases; Ligases
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; Siemens Healthineers AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. In Vitro Diagnostics Enzymes Market Characteristics

3. In Vitro Diagnostics Enzymes Market Trends And Strategies

4. In Vitro Diagnostics Enzymes Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global In Vitro Diagnostics Enzymes Growth Analysis And Strategic Analysis Framework

• 5.1. Global In Vitro Diagnostics Enzymes PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global In Vitro Diagnostics Enzymes Market Growth Rate Analysis
• 5.4. Global In Vitro Diagnostics Enzymes Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global In Vitro Diagnostics Enzymes Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global In Vitro Diagnostics Enzymes Total Addressable Market (TAM)

6. In Vitro Diagnostics Enzymes Market Segmentation

• 6.1. Global In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Proteases
• Polymerase And Transcriptase
• Ribonuclease
• Other Enzyme Types
• 6.2. Global In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infectious Disease
• Diabetes
• Oncology
• Cardiology
• Nephrology
• Autoimmune Diseases
• Other Disease Types
• 6.3. Global In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Histology Assays
• Molecular Diagnostics
• Clinical Chemistry
• Other Technologies
• 6.4. Global In Vitro Diagnostics Enzymes Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharma And Biotech
• Hospital And Diagnostic Labs
• Contract Research Organizations (CROs)
• Academic Labs
• 6.5. Global In Vitro Diagnostics Enzymes Market, Sub-Segmentation Of Proteases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Trypsin
• Pepsin
• Proteinase K
• 6.6. Global In Vitro Diagnostics Enzymes Market, Sub-Segmentation Of Polymerase And Transcriptase, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• DNA Polymerase
• RNA Polymerase
• Reverse Transcriptase
• 6.7. Global In Vitro Diagnostics Enzymes Market, Sub-Segmentation Of Ribonuclease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• RNase A
• RNase H
• 6.8. Global In Vitro Diagnostics Enzymes Market, Sub-Segmentation Of Other Enzyme Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dehydrogenases
• Lipases
• Ligases

7. In Vitro Diagnostics Enzymes Market Regional And Country Analysis

• 7.1. Global In Vitro Diagnostics Enzymes Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global In Vitro Diagnostics Enzymes Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific In Vitro Diagnostics Enzymes Market

• 8.1. Asia-Pacific In Vitro Diagnostics Enzymes Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China In Vitro Diagnostics Enzymes Market

• 9.1. China In Vitro Diagnostics Enzymes Market Overview
• 9.2. China In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India In Vitro Diagnostics Enzymes Market

• 10.1. India In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan In Vitro Diagnostics Enzymes Market

• 11.1. Japan In Vitro Diagnostics Enzymes Market Overview
• 11.2. Japan In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia In Vitro Diagnostics Enzymes Market

• 12.1. Australia In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia In Vitro Diagnostics Enzymes Market

• 13.1. Indonesia In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea In Vitro Diagnostics Enzymes Market

• 14.1. South Korea In Vitro Diagnostics Enzymes Market Overview
• 14.2. South Korea In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe In Vitro Diagnostics Enzymes Market

• 15.1. Western Europe In Vitro Diagnostics Enzymes Market Overview
• 15.2. Western Europe In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK In Vitro Diagnostics Enzymes Market

• 16.1. UK In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany In Vitro Diagnostics Enzymes Market

• 17.1. Germany In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France In Vitro Diagnostics Enzymes Market

• 18.1. France In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy In Vitro Diagnostics Enzymes Market

• 19.1. Italy In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain In Vitro Diagnostics Enzymes Market

• 20.1. Spain In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe In Vitro Diagnostics Enzymes Market

• 21.1. Eastern Europe In Vitro Diagnostics Enzymes Market Overview
• 21.2. Eastern Europe In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia In Vitro Diagnostics Enzymes Market

• 22.1. Russia In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America In Vitro Diagnostics Enzymes Market

• 23.1. North America In Vitro Diagnostics Enzymes Market Overview
• 23.2. North America In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA In Vitro Diagnostics Enzymes Market

• 24.1. USA In Vitro Diagnostics Enzymes Market Overview
• 24.2. USA In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada In Vitro Diagnostics Enzymes Market

• 25.1. Canada In Vitro Diagnostics Enzymes Market Overview
• 25.2. Canada In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America In Vitro Diagnostics Enzymes Market

• 26.1. South America In Vitro Diagnostics Enzymes Market Overview
• 26.2. South America In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil In Vitro Diagnostics Enzymes Market

• 27.1. Brazil In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East In Vitro Diagnostics Enzymes Market

• 28.1. Middle East In Vitro Diagnostics Enzymes Market Overview
• 28.2. Middle East In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa In Vitro Diagnostics Enzymes Market

• 29.1. Africa In Vitro Diagnostics Enzymes Market Overview
• 29.2. Africa In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. In Vitro Diagnostics Enzymes Market Competitive Landscape And Company Profiles

• 30.1. In Vitro Diagnostics Enzymes Market Competitive Landscape
• 30.2. In Vitro Diagnostics Enzymes Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. In Vitro Diagnostics Enzymes Market Other Major And Innovative Companies

• 31.1. Becton Dickinson and Company
• 31.2. Agilent Technologies Inc.
• 31.3. Grifols SA
• 31.4. Hologic Inc.
• 31.5. Illumina Inc.
• 31.6. Mindray Medical International Limited
• 31.7. PerkinElmer Inc.
• 31.8. bioMerieux SA
• 31.9. QuidelOrtho Corporation
• 31.10. Sysmex Corporation
• 31.11. Bio-Rad Laboratories Inc.
• 31.12. Qiagen N.V.
• 31.13. DiaSorin SpA
• 31.14. Promega Corporation
• 31.15. Randox Laboratories Ltd.

32. Global In Vitro Diagnostics Enzymes Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The In Vitro Diagnostics Enzymes Market

34. Recent Developments In The In Vitro Diagnostics Enzymes Market

35. In Vitro Diagnostics Enzymes Market High Potential Countries, Segments and Strategies

• 35.1 In Vitro Diagnostics Enzymes Market In 2029 - Countries Offering Most New Opportunities
• 35.2 In Vitro Diagnostics Enzymes Market In 2029 - Segments Offering Most New Opportunities
• 35.3 In Vitro Diagnostics Enzymes Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer